Published in Medical Letter on the CDC and FDA, August 23rd, 1999
This dramatic decrease is linked to the use of zidovudine (AZT) by HIV infected mothers. AZT taken during pregnancy greatly reduces the chance that an HIV infected woman will transmit the virus to her child. In 1994 the U.S. Public Health Service (PHS) recommended that all HIV positive pregnant women receive AZT.
CDC researcher Mary Lou Lindegren and colleagues analyzed U.S. AIDS surveillance data, including information from HIV reporting states, collected through June 1998.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA